The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of eplerenone (Epe) in the management of mineralocorticoid excess (MCE) in men with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone (AA) without prednisone (P).
 
David Michael Gill
No Relationships to Disclose
 
David Gaston
No Relationships to Disclose
 
Andrew W. Hahn
No Relationships to Disclose
 
Erin B. Bailey
No Relationships to Disclose
 
Tyler Howard Buckley
No Relationships to Disclose
 
Eric Johnson
No Relationships to Disclose
 
Julia A. Batten
No Relationships to Disclose
 
Anitha Alex
No Relationships to Disclose
 
Kenneth M. Boucher
No Relationships to Disclose
 
David D. Stenehjem
No Relationships to Disclose
 
Neeraj Agarwal
Research Funding - amgen (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Rexahn Pharmaceuticals (Inst); Takeda (Inst); TRACON Pharma (Inst)